Prognostic factors of local control and progression-free survival in AJCC stages T1 and T2 cervical cancer patients treated with adjuvant brachytherapy after chemoradiotherapy.

Date publication

février 2023

Journal

Journal of contemporary brachytherapy

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MARCHAL Frédéric , Pr PEIFFERT Didier , Dr FAIVRE Jean-Christophe

Tous les auteurs :
Faivre JC, Jung P, Salleron J, Baumard F, Courrech F, Marchal F, Peiffert D, Renard S, Charra-Brunaud C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36970434

Résumé

We assessed prognostic factors of local control and progression-free survival (PFS) of patients treated for AJCC stages T1 and T2 cervical cancer using utero-vaginal brachytherapy after chemoradiotherapy.

Mots clés

brachytherapy, radiotherapy, surgery, toxicity, uterine cervical neoplasms

Référence

J Contemp Brachytherapy. 2023 02;15(1):27-36